New radiation tech aims to spare cancer patients from severe diarrhea
NCT ID NCT05295992
Summary
This trial is testing a more precise, daily-adapted form of radiation therapy for muscle-invasive bladder cancer. The main goal is to see if this method causes fewer severe intestinal side effects, like diarrhea, compared to standard radiation. It involves 110 participants and focuses on improving patients' quality of life during treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE BLADDER CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Herlev and Gentofte Hospital
Herlev, DK-2730, Denmark
Conditions
Explore the condition pages connected to this study.